Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Baxter
Express Scripts
Accenture
Chinese Patent Office
Merck
AstraZeneca
Argus Health
Covington

Generated: May 22, 2018

DrugPatentWatch Database Preview

CERETEC Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Ceretec, and what generic alternatives are available?

Ceretec is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in CERETEC is technetium tc-99m exametazime kit. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the technetium tc-99m exametazime kit profile page.
Summary for CERETEC
US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: 2
Clinical Trials: 2
DailyMed Link:CERETEC at DailyMed
Drug patent expirations by year for CERETEC
Pharmacology for CERETEC

US Patents and Regulatory Information for CERETEC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare CERETEC technetium tc-99m exametazime kit INJECTABLE;INJECTION 019829-001 Dec 30, 1988 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for CERETEC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Healthcare CERETEC technetium tc-99m exametazime kit INJECTABLE;INJECTION 019829-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Ge Healthcare CERETEC technetium tc-99m exametazime kit INJECTABLE;INJECTION 019829-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cerilliant
Federal Trade Commission
Accenture
Express Scripts
AstraZeneca
Cipla
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.